These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
343 related articles for article (PubMed ID: 34239274)
1. High rate of complete histopathological response in hepatocellular carcinoma patients after combined transarterial chemoembolization and stereotactic body radiation therapy. Bauer U; Gerum S; Roeder F; Münch S; Combs SE; Philipp AB; De Toni EN; Kirstein MM; Vogel A; Mogler C; Haller B; Neumann J; Braren RF; Makowski MR; Paprottka P; Guba M; Geisler F; Schmid RM; Umgelter A; Ehmer U World J Gastroenterol; 2021 Jun; 27(24):3630-3642. PubMed ID: 34239274 [TBL] [Abstract][Full Text] [Related]
2. Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis. Sapisochin G; Barry A; Doherty M; Fischer S; Goldaracena N; Rosales R; Russo M; Beecroft R; Ghanekar A; Bhat M; Brierley J; Greig PD; Knox JJ; Dawson LA; Grant DR J Hepatol; 2017 Jul; 67(1):92-99. PubMed ID: 28257902 [TBL] [Abstract][Full Text] [Related]
3. Combined therapy of transarterial chemoembolization and stereotactic body radiation therapy versus transarterial chemoembolization for ≤5cm hepatocellular carcinoma: Propensity score matching analysis. Jun BG; Kim SG; Kim YD; Cheon GJ; Han KH; Yoo JJ; Kim YS; Jeong SW; Jang JY; Lee SH; Park S; Kim HS PLoS One; 2018; 13(10):e0206381. PubMed ID: 30379885 [TBL] [Abstract][Full Text] [Related]
4. A Pilot Trial Evaluating Stereotactic Body Radiation Therapy to Induce Hyperemia in Combination With Transarterial Chemoembolization for Hepatocellular Carcinoma. Sebastian NT; Miller ED; Yang X; Diaz DA; Tan Y; Dowell J; Spain J; Rikabi A; Elliott E; Knopp M; Williams TM Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1276-1283. PubMed ID: 32712254 [TBL] [Abstract][Full Text] [Related]
5. Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant. Wong TC; Lee VH; Law AL; Pang HH; Lam KO; Lau V; Cui TY; Fong AS; Lee SW; Wong EC; Dai JW; Chan AC; Cheung TT; Fung JY; Yeung RM; Luk MY; Leung TW; Lo CM Hepatology; 2021 Nov; 74(5):2580-2594. PubMed ID: 34091914 [TBL] [Abstract][Full Text] [Related]
6. Stereotactic Body Radiation Therapy With or Without Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone in Early-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Dumago MP; Agas RAF; Jainar CJE; Yap ET; Co LBA; Ortin TTS J Gastrointest Cancer; 2023 Dec; 54(4):1058-1070. PubMed ID: 37306936 [TBL] [Abstract][Full Text] [Related]
7. Thermal Ablation Versus Stereotactic Body Radiotherapy After Transarterial Chemoembolization for Inoperable Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis. Nabavizadeh N; Jahangiri Y; Rahmani R; Tomozawa Y; Geeratikun Y; Chen Y; Hung A; Degnin C; Farsad K AJR Am J Roentgenol; 2021 Sep; 217(3):691-698. PubMed ID: 32997517 [No Abstract] [Full Text] [Related]
8. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm. Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890 [TBL] [Abstract][Full Text] [Related]
9. Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular Carcinoma. Shen PC; Chang WC; Lo CH; Yang JF; Lee MS; Dai YH; Lin CS; Fan CY; Huang WY Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):307-318. PubMed ID: 31175903 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Stereotactic Body Radiation Therapy Combined With or Without Transcatheter Arterial Chemoembolization for Patients With Small Hepatocellular Carcinoma Ineligible for Resection or Ablation Therapies. Kimura T; Aikata H; Doi Y; Imano N; Takeuchi Y; Takahashi I; Nishibuchi I; Katsuta T; Kenjo M; Murakami Y; Awai K; Chayama K; Nagata Y Technol Cancer Res Treat; 2018 Jan; 17():1533033818783450. PubMed ID: 29963972 [TBL] [Abstract][Full Text] [Related]
11. Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis. Wong TC; Chiang CL; Lee AS; Lee VH; Yeung CS; Ho CH; Cheung TT; Ng KK; Chok SH; Chan AC; Dai WC; Wong FC; Luk MY; Leung TW; Lo CM Surg Oncol; 2019 Mar; 28():228-235. PubMed ID: 30851906 [TBL] [Abstract][Full Text] [Related]
12. Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma. Sapir E; Tao Y; Schipper MJ; Bazzi L; Novelli PM; Devlin P; Owen D; Cuneo KC; Lawrence TS; Parikh ND; Feng M Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):122-130. PubMed ID: 29066120 [TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis. Choi BO; Choi IB; Jang HS; Kang YN; Jang JS; Bae SH; Yoon SK; Chai GY; Kang KM BMC Cancer; 2008 Nov; 8():351. PubMed ID: 19038025 [TBL] [Abstract][Full Text] [Related]
14. Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation. Takeda A; Sanuki N; Tsurugai Y; Iwabuchi S; Matsunaga K; Ebinuma H; Imajo K; Aoki Y; Saito H; Kunieda E Cancer; 2016 Jul; 122(13):2041-9. PubMed ID: 27062278 [TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiotherapy based treatment for hepatocellular carcinoma with extensive portal vein tumor thrombosis. Shui Y; Yu W; Ren X; Guo Y; Xu J; Ma T; Zhang B; Wu J; Li Q; Hu Q; Shen L; Bai X; Liang T; Wei Q Radiat Oncol; 2018 Sep; 13(1):188. PubMed ID: 30253783 [TBL] [Abstract][Full Text] [Related]
16. Comparison between Trans-Arterial Chemoembolization Followed by Stereotactic Body Radiation Therapy and Trans-Arterial Chemoembolization Alone in BCLC Stage B Hepatocellular Carcinoma: A Pilot Study. Saad E; Abdulla M; Nassef A; Ebrahim N; Abdel Moneim R Asian Pac J Cancer Prev; 2024 Sep; 25(9):3073-3079. PubMed ID: 39342585 [TBL] [Abstract][Full Text] [Related]
17. Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma. Honda Y; Kimura T; Aikata H; Kobayashi T; Fukuhara T; Masaki K; Nakahara T; Naeshiro N; Ono A; Miyaki D; Nagaoki Y; Kawaoka T; Takaki S; Hiramatsu A; Ishikawa M; Kakizawa H; Kenjo M; Takahashi S; Awai K; Nagata Y; Chayama K J Gastroenterol Hepatol; 2013 Mar; 28(3):530-6. PubMed ID: 23216217 [TBL] [Abstract][Full Text] [Related]
18. Stereotactic body radiation therapy as a salvage treatment for single viable hepatocellular carcinoma at the site of incomplete transarterial chemoembolization: a retrospective analysis of 302 patients. Lee S; Jung J; Park JH; Kim SY; Choi J; Lee D; Shim JH; Kim KM; Lim YS; Lee HC; Park HH; Kim JH; Yoon SM BMC Cancer; 2022 Feb; 22(1):175. PubMed ID: 35172769 [TBL] [Abstract][Full Text] [Related]
19. Combined transarterial chemoembolization and thermal ablation in candidates to liver transplantation with hepatocellular carcinoma: pathological findings and post-transplant outcome. Fronda M; Susanna E; Doriguzzi Breatta A; Gazzera C; Patrono D; Piccione F; Bertero L; Ciferri F; Carucci P; Gaia S; Rolle E; Vocino Trucco G; Bergamasco L; Tandoi F; Cassoni P; Romagnoli R; Fonio P; Calandri M Radiol Med; 2024 Jul; 129(7):1086-1097. PubMed ID: 38829544 [TBL] [Abstract][Full Text] [Related]
20. Stereotactic body radiotherapy plus transcatheter arterial chemoembolization for inoperable hepatocellular carcinoma patients with portal vein tumour thrombus: A meta-analysis. Zhang XF; Lai L; Zhou H; Mo YJ; Lu XQ; Liu M; Lu YX; Hou EC PLoS One; 2022; 17(5):e0268779. PubMed ID: 35594278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]